Edukad projektid

eesti keeles / in English

Linking research organisations in the fields of Tissue Engineering and Regenerative Medicine through European cooperation between regional research clusters

acronym: TERM
start: 2010-10-01
end: 2013-09-30
 
programme: FP7 - Euroopa Liidu 7. raamprogramm
sub-programme: REGIONS - Teadmiste piirkonnad
instrument: CSA-CA - Koordineerivad ja toetavad tegevused - koordineerivad tegevused
call identifier: FP7-REGIONS-2010-1
project number: 265546
duration in months: 36
partner count: 14
 
abstract: The development of innovative 'Advanced Therapies' offers new approaches to tackle major diseases such as cancer, diabetes, Alzheimer or Parkinson. The progress made in the fields of 'Tissue Engineering' and 'Regenerative Medicine' (TERM) promises to deliver long awaited new solutions. They are recognized as potential sources for medical progress and significant economic growth where Europe should position itself. Since advanced therapies are often based on personalized medicine, the translation of medical developments into real-life, sustainable therapies is challenged by several hurtles. We need new scientific (multi-disciplinary, GMP-conform research environment), economic (new business models for high-cost-low frequency treatments) and structural (translation-oriented RTD) solutions. Europe has to improve its research capacities and accelerate translation to catch up with the US and keep ahead of rapidly developing Asian countries. TERM project aims at a consolidating skills and infrastructures among European regions and their research clusters through the definition of joint actions and mentoring. The goal is to derive high potential, translation-oriented projects from joining skill-sets, infrastructures and networks and from recognizing the requirements of the market forces. The financing situation shall also be analyzed and adapted to the requirements. TERM project will develop knowledge and strategies on how to use resources of the regions and clusters more efficiently with more synergy and focus. The knowledge generated shall be used to develop tools to efficiently assess the research potential of a region, implement best practices in a research cluster, develop inter-regional programs with joined research goals and suggest financial instruments that support these efforts. Therefore, the output of our project will be the development of a European strategy, action plan and best practice tools on how to link research clusters from different regions
partner no and role partner name country contact person web page
1 coordinator SYNDICAT MIXTE ATLANPOLE FR Maud Tronchin http://www.atlanpole.fr
2 partner Medcoast Scandinavia NO Annelie Näslund http://www.medcoast.org
3 partner FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR IT Mario Valsecchi http://www.sanraffaele.org
5 partner BIOWIN ASBL BE Severine Van Houcke http://www.biowin.org
6 partner ASOCIACION MADRID PLATAFORMA DE LA BIOTECNOLOGÍA ES Jesus Egea http://www.madridnetwork.org/red/madrid_biocluster
7 partner BALTIC INNOVATION AGENCY OÜ EE Rene Tonnisson http://www.bia.ee
8 partner CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE Eveline Fräßdorf http://www.charite.de
9 partner Interface Europe BE Landry Cochard http://www.interfaceurope.eu
10 partner Région des Pays de la Loire FR Philippe Haertel http://www.paysdelaloire.fr
11 partner CONSEJERIA DE ECONOMIA Y HACIENDA - COMUNIDAD DE MADRID ES Julia Prieto http://www.madrid.org
12 partner SERVICE PUBLIC DE WALLONIE BE Thierry Lemoine http://spw.wallonie.be
13 partner VERKET FÖR INNOVATIONSSYSTEM SE Anne Lidgard http://www.vinnova.se
14 partner REGIONFORBUNDET UPPSALA LAN SE Maria Didi http://www.regionuppsala.se
15 partner STIFTELSEN FOR SAMVERKAN MELLAN UNIVERSITETEN I UPPSALA, NARINGSLIV OCH SAMHALLE SE Margita Gunnarsson http://www.stuns.se